CIBIS III: β-blockade best upfront for chronic heart failure?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1556, 2006-01, pp. : 17-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin-Like Growth Factor I: An Attractive Option for Chronic Heart Failure?

By Donath M.Y. Zapf J.

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 251-254

Adis International

Access to resources Recommend Favorite

Should -Blockers be Used for the Treatment of Pediatric Patients with Chronic Heart Failure?

By Bruns L.A.

Pediatric Drugs, Vol. 4, Iss. 12, 2002-01 ,pp. : 771-778

Adis International

Access to resources Recommend Favorite

Start statins stat for patients with heart failure?

Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Oral glucocorticoid use a risk factor for heart failure?

Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

-Blockers have a role in severe heart failure?

Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite